Thomas Kocher
Salzburg, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Engineered natural extracellular matrix platform for modelling skin diseases and therapeutic targets discovery.
Journal: Journal of advanced research
Published: December 09, 2025
Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosa.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 25, 2025
HMCN1 variants aggravate epidermolysis bullosa simplex phenotype.
Journal: The Journal of experimental medicine
Published: May 11, 2024
Splicing Modulation via Antisense Oligonucleotides in Recessive Dystrophic Epidermolysis Bullosa.
Journal: International journal of molecular sciences
Published: December 01, 2023
On- and off-target effects of paired CRISPR-Cas nickase in primary human cells.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 30, 2023
Genetics in sports-muscle injuries
Journal: Orthopadie (Heidelberg, Germany)
Published: August 17, 2023
A Novel Fluorescence-Based Screen of Gene Editing Molecules for Junctional Epidermolysis Bullosa.
Journal: International journal of molecular sciences
Published: February 07, 2023
COL7A1 Editing via RNA Trans-Splicing in RDEB-Derived Skin Equivalents.
Journal: International journal of molecular sciences
Published: December 21, 2022
COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa.
Journal: Frontiers in medicine
Published: June 23, 2022
Current developments in gene therapy for epidermolysis bullosa.
Journal: Expert opinion on biological therapy
Published: March 02, 2022
Last Updated: 09/26/2026